WASHINGTON - Privately held Protein Sciences Corp. Inc. won a $35 million Health and Human Services (HHS) contract, which could be extended to $147 million over five years, to support the Meriden, Conn.-based firm's recombinant baculovirus influenza vaccine technology. (BioWorld Today) Read More